Home/Filings/4/0001127602-24-003478
4//SEC Filing

Ridha Essra 4

Accession 0001127602-24-003478

CIK 0001681087other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 7:59 PM ET

Size

8.2 KB

Accession

0001127602-24-003478

Insider Transaction Report

Form 4
Period: 2024-02-01
Ridha Essra
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-01+32,83432,834 total
  • Tax Payment

    Common Stock

    2024-02-05$1.20/sh16,953$20,35415,881 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-0132,83498,499 total
    Exercise: $0.00Exp: 2027-02-01Common Stock (32,834 underlying)
Footnotes (1)
  • [F1]The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.

Issuer

AVROBIO, Inc.

CIK 0001681087

Entity typeother

Related Parties

1
  • filerCIK 0001888732

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:59 PM ET
Size
8.2 KB